Antiatherogenic properties of metformin: the experimental evidence
- 1 September 2003
- journal article
- review article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 29 (4) , 6S71-6S76
- https://doi.org/10.1016/s1262-3636(03)72790-6
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Metformin inhibits monocyte adhesion to endothelial cells and foam cell formationBritish Journal of Diabetes, 2003
- Metformin, but not Thiazolidinediones, Inhibits Plasminogen Activator Inhibitor-1 Production in Human Adipose Tissuein VitroHormone and Metabolic Research, 2003
- Review: The genetics of macrovascular disease in diabetesBritish Journal of Diabetes, 2002
- Review: The pathogenesis of type 2 diabetes and cardiovascular diseaseBritish Journal of Diabetes, 2002
- Experimental atherosclerosisLife Sciences, 2002
- The Antihyperglycaemic Effect of MetforminDrugs, 1999
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Treatment with low dose metformin in patients with peripheral vascular diseasePharmacological Research, 1992
- Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbitsAtherosclerosis, 1982
- Effect of metformin on lipid metabolism in the rabbit aortic wallAtherosclerosis, 1978